Old Web
English
Sign In
Acemap
>
authorDetail
>
Ting Yu
Ting Yu
AstraZeneca
Medicine
Idelalisib
Bendamustine
Oncology
relapsed refractory
2
Papers
0
Citations
0
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
New Acalabrutinib Formulation Enables Co-Administration with Proton Pump Inhibitors and Dosing in Patients Unable to Swallow Capsules (ELEVATE-PLUS)
2021
Blood
Shringi Sharma
Xavier Pepin
Harini Burri
Lianqing Zheng
Nataliya Kuptsova-Clarkson
Anouk de Jong
Ting Yu
Holly L MacArthur
Michal Majewski
Joseph Ware
James Mann
David Ramies
Veerendra Munugalavadla
Louise Sheridan
Helen Tomkinson
Show All
Source
Cite
Save
Citations (0)
Three-Year Follow-up of the Ascend Trial: Acalabrutinib Vs Rituximab Plus Idelalisib or Bendamustine in Relapsed/Refractory Chronic Lymphocytic Leukemia
2021
Blood
Wojciech Jurczak
Andrzej Pluta
Malgorzata Wach
Daniel Lysák
Tomas Kozak
Martin Simkovic
Iryna Kriachok
Árpád Illés
Javier de la Serna
Sean Dolan
Philip Campbell
Gerardo Musuraca
Abraham Jacob
Eric J. Avery
Jae Hoon Lee
Min Hui Wang
Ting Yu
Paolo Ghia
Show All
Source
Cite
Save
Citations (0)
1
map